131 related articles for article (PubMed ID: 17578734)
1. Eudragit microparticles as a possible tool for ophthalmic administration of acyclovir.
Cortesi R; Ajanji SC; Sivieri E; Manservigi M; Fundueanu G; Menegatti E; Esposito E
J Microencapsul; 2007 Aug; 24(5):445-56. PubMed ID: 17578734
[TBL] [Abstract][Full Text] [Related]
2. Production of Eudragit microparticles by spray-drying technique: influence of experimental parameters on morphological and dimensional characteristics.
Esposito E; Roncarati R; Cortesi R; Cervellati F; Nastruzzi C
Pharm Dev Technol; 2000; 5(2):267-78. PubMed ID: 10810756
[TBL] [Abstract][Full Text] [Related]
3. Cationic Eudragit® polymers as excipients for microparticles prepared by solvent evaporation method.
Vysloužil J; Bavoľárová J; Kejdušová M; Vetchý D; Dvořáčková K
Ceska Slov Farm; 2013 Dec; 62(6):249-54. PubMed ID: 24393112
[TBL] [Abstract][Full Text] [Related]
4. Spray dried Eudragit microparticles as encapsulation devices for vitamin C.
Esposito E; Cervellati F; Menegatti E; Nastruzzi C; Cortesi R
Int J Pharm; 2002 Aug; 242(1-2):329-34. PubMed ID: 12176273
[TBL] [Abstract][Full Text] [Related]
5. Increased efficacy of acyclovir-loaded microparticles against herpes simplex virus type 1 in cell culture.
de Jalón EG; Blanco-Príeto MJ; Ygartua P; Santoyo S
Eur J Pharm Biopharm; 2003 Sep; 56(2):183-7. PubMed ID: 12957631
[TBL] [Abstract][Full Text] [Related]
6. Engineering polymer blend microparticles: an investigation into the influence of polymer blend distribution and interaction.
Alhnan MA; Basit AW
Eur J Pharm Sci; 2011 Jan; 42(1-2):30-6. PubMed ID: 20950685
[TBL] [Abstract][Full Text] [Related]
7. Floating properties and release characteristics of hollow microspheres of acyclovir.
Junyaprasert VB; Pornsuwannapha S
Drug Deliv; 2008 Jun; 15(5):331-41. PubMed ID: 18763164
[TBL] [Abstract][Full Text] [Related]
8. Co-encapsulation of acyclovir and curcumin into microparticles improves the physicochemical characteristics and potentiates in vitro antiviral action: Influence of the polymeric composition.
Reolon JB; Brustolin M; Accarini T; Viçozzi GP; Sari MHM; Bender EA; Haas SE; Brum MCS; Gündel A; Colomé LM
Eur J Pharm Sci; 2019 Apr; 131():167-176. PubMed ID: 30790703
[TBL] [Abstract][Full Text] [Related]
9. Encapsulation of Acyclovir in new carboxylated cyclodextrin-based nanosponges improves the agent's antiviral efficacy.
Lembo D; Swaminathan S; Donalisio M; Civra A; Pastero L; Aquilano D; Vavia P; Trotta F; Cavalli R
Int J Pharm; 2013 Feb; 443(1-2):262-72. PubMed ID: 23279938
[TBL] [Abstract][Full Text] [Related]
10. Multiple unit gastroretentive drug delivery systems: a new preparation method for low density microparticles.
Streubel A; Siepmann J; Bodmeier R
J Microencapsul; 2003; 20(3):329-47. PubMed ID: 12881114
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of burst release from pH-responsive polymeric microparticles.
Rizi K; Green RJ; Khutoryanskaya O; Donaldson M; Williams AC
J Pharm Pharmacol; 2011 Sep; 63(9):1141-55. PubMed ID: 21827486
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of drug-loaded polymethacrylate microspheres by an emulsion solvent evaporation method.
Kim BK; Hwang SJ; Park JB; Park HJ
J Microencapsul; 2002; 19(6):811-22. PubMed ID: 12569029
[TBL] [Abstract][Full Text] [Related]
13. The potency of acyclovir can be markedly different in different cell types.
Brand G; Schiavano GF; Balestra E; Tavazzi B; Perno CF; Magnani M
Life Sci; 2001 Aug; 69(11):1285-90. PubMed ID: 11521752
[TBL] [Abstract][Full Text] [Related]
14. Enhanced antiviral activity of Acyclovir loaded into beta-cyclodextrin-poly(4-acryloylmorpholine) conjugate nanoparticles.
Cavalli R; Donalisio M; Civra A; Ferruti P; Ranucci E; Trotta F; Lembo D
J Control Release; 2009 Jul; 137(2):116-22. PubMed ID: 19361545
[TBL] [Abstract][Full Text] [Related]
15. Bioadhesive microspheres for ophthalmic administration of acyclovir.
Genta I; Conti B; Perugini P; Pavanetto F; Spadaro A; Puglisi G
J Pharm Pharmacol; 1997 Aug; 49(8):737-42. PubMed ID: 9379347
[TBL] [Abstract][Full Text] [Related]
16. Controlled ocular delivery of acyclovir through rate controlling ocular insert of Eudragit: a technical note.
Khan S; Ali A; Singhavi D; Yeole P
AAPS PharmSciTech; 2008; 9(1):169-73. PubMed ID: 18446478
[No Abstract] [Full Text] [Related]
17. Topical application of acyclovir-loaded microparticles: quantification of the drug in porcine skin layers.
de Jalón EG; Blanco-Príeto MJ; Ygartua P; Santoyo S
J Control Release; 2001 Jul; 75(1-2):191-7. PubMed ID: 11451509
[TBL] [Abstract][Full Text] [Related]
18. Preparation and in vitro evaluation of Eudragit microspheres containing acetazolamide.
Haznedar S; Dortunç B
Int J Pharm; 2004 Jan; 269(1):131-40. PubMed ID: 14698584
[TBL] [Abstract][Full Text] [Related]
19. Effect of dimeric netropsin analogue 15Lys-bis-Nt and acyclovir on the reproduction of herpes simplex virus type 1. The search for variants of herpes virus with drug resistance to 15Lys-bis-Nt and acyclovir.
Andronova VL; Grokhovsky SL; Surovaya AN; Gursky GV; Galegov GA
Dokl Biochem Biophys; 2015; 460():42-6. PubMed ID: 25772989
[No Abstract] [Full Text] [Related]
20. The size-reduced Eudragit® RS microparticles prepared by solvent evaporation method - monitoring the effect of selected variables on tested parameters.
Vasileiou K; Vysloužil J; Pavelková M; Vysloužil J; Kubová K
Ceska Slov Farm; 2018; 66(6):274-280. PubMed ID: 29623709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
